DAM
ENTX icon

DLD Asset Management’s Entera Bio ENTX Stock Holding History

DLD Asset Management’s Portfolio ENTX Stock Details ENTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-344,256
Closed -$48K – 98
2020
Q3 		$48K Buy
+344,256
New +$522K ﹤0.01% 78

Other funds holding ENTX

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

DLD Asset Management's ENTX Position: Q4 2019 in Review

DLD Asset Management sold out of Entera Bio (ENTX) in Q4 2019, closing a stake of 369,000 shares — an estimated $919K sold.

DLD Asset Management first reported a position in ENTX in Q2 2018 and held it in 6 quarters. The position peaked at $1.63M in Q3 2018. 3 funds tracked by Wall St. Rank hold ENTX as of Q4 2019.

  • DLD Asset Management reported no remaining Entera Bio position as of Q4 2019 after selling out during the quarter.
  • DLD Asset Management sold 369,000 Entera Bio shares in Q4 2019, an estimated $919K.
  • DLD Asset Management first reported a position in Entera Bio in Q2 2018 and held it in 6 quarters.
  • DLD Asset Management's Entera Bio position peaked at $1.63M in Q3 2018.
  • 3 funds tracked by Wall St. Rank held Entera Bio as of Q4 2019.

Based on DLD Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.